adplus-dvertising
Connect with us

Health

Factbox-Vaccines delivered under COVAX sharing scheme for poorer countries

Published

 on

The COVAX facility, backed by the World Health Organization (WHO) and the Global Alliance for Vaccines and Immunization (GAVI), has delivered 1.22 billion COVID-19 vaccine doses to 144 countries, GAVI data shows.

In December, COVAX set a target of achieving 70% COVID-19 immunization coverage by mid-2022.

The following tables list countries that have received vaccines under the scheme, sorted alphabetically:

AFRICA & MIDDLE EAST

COUNTRY LATEST DELIVERY DATE VACCINE TYPE POPULATION TOTAL

DELIVERY DELIVERED

Algeria 3.6 million December 24 J&J 44 million 6.0 million

Angola 801,000 December 25 Pfizer/BioNTech 33 million 14.8 million

Benin 336,000 November 4 J&J 12 million 1.1 million

Botswana 300,000 October 1 AstraZeneca/Oxford 2.5 million 560,460

Burkina Faso 504,000 December 22 J&J 21 million 1.1 million

Cameroon 336,000 November 5 J&J 27 million 1.0 million

Cape Verde 200,000 December 7 Pfizer/BioNTech 556,000 324,000

Central 168,300 November 19 J&J 4.8 million 806,700

African

Republic

Chad 117,000 October 5 Pfizer/BioNTech 16 million 217,620

Comoros 12,000 April 12 AstraZeneca/Oxford 870,000 12,000

Islands

Congo 168,000 November 15 J&J 5.5 million 470,400

Democratic 349,830 October 21 Pfizer/BioNTech 90 million 2.6 million

Republic of

Congo

Djibouti 151,200 July 17 J&J 988,000 175,200

Egypt 2.2 million February 20 Pfizer/BioNTech 102 million 29.0 million

Eswatini 100,620 October 6 Pfizer/BioNTech 1.1 million 429,420

Ethiopia 13.1 February 2 J&J 115 million 27.5 million

million

Gabon 101,790 November 1 Pfizer/BioNTech 2.2 million 370,410

Gambia 38,400 August 22 AstraZeneca/Oxford 2.4 million 376,800

Ghana 1.7 million December 24 Pfizer/BioNTech 31 million 16.3 million

Guinea 168,000 November 14 J&J 13 million 1.7 million

Guinea-Bissau 28,800 August 18 AstraZeneca/Oxford 2.0 million 360,000

Iran 700,000 January 14 AstraZeneca/Oxford 84 million 5.7 million

Iraq 500,000 August 14 Pfizer/BioNTech 40 million 836,000

Ivory Coast 816,660 January 3 Pfizer/BioNTech 26 million 8.6 million

Jordan 146,400 June 3 AstraZeneca/Oxford 10 million 436,800

Kenya 500,000 January 29 Pfizer/BioNTech 54 million 16.7 million

Lebanon 613,340 December 22 N/A 6.8 million 982,940

Lesotho 169,070 November 19 J&J 2.1 million 644,090

Liberia 168,000 November 27 J&J 5.1 million 830,400

Libya 1.2 million December 20 Pfizer/BioNTech 6.9 million 1.9 million

Madagascar 240,000 February 17 J&J 28 million 1.9 million

Malawi 360,000 October 23 AstraZeneca/Oxford 19 million 1.8 million

Mali 50,400 January 7 AstraZeneca/Oxford 20 million 1.7 million

Mauritania 201,600 February 7 AstraZeneca/Oxford 4.6 million 2.2 million

Mauritius 203,580 January 12 Pfizer/BioNTech 1.3 million 387,270

Morocco 1.5 million January 29 Pfizer/BioNTech 37 million 2.7 million

Mozambique 1.2 million February 11 AstraZeneca/Oxford 31 million 8.4 million

Namibia 168,000 February 18 J&J 2.5 million 492,800

Niger 398,000 February 4 Pfizer/BioNTech 24 million 1.6 million

Nigeria 2.0 million February 7 J&J 206 million 17.2 million

Palestinian 203,580 January 31 Pfizer/BioNTech 4.7 million 1.3 million

Territories

Rwanda 1.1 million January 15 N/A 13 million 3.9 million

Sao Tome and 24,000 March 3 AstraZeneca/Oxford 219,000 24,000

Principe

Senegal 302,400 February 10 J&J 17 million 3.2 million

Seychelles 39,780 December 17 Pfizer/BioNTech 98,460 74,880

Sierra Leone 168,000 November 23 J&J 8.0 million 785,310

Somalia 336,500 November 7 J&J 16 million 1.2 million

South Africa 5.6 million July 31 Pfizer/BioNTech 59 million 5.6 million

South Sudan 336,000 December 21 J&J 11 million 908,450

Sudan 604,800 February 16 J&J 44 million 3.9 million

Syria 4.0 million January 26 J&J 17 million 5.7 million

Tanzania 1.6 million January 19 Pfizer/BioNTech 60 million 4.7 million

Togo 633,600 November 25 J&J 8.3 million 3.0 million

Tunisia 310,050 January 28 Pfizer/BioNTech 12 million 4.4 million

Uganda 433,300 February 16 Moderna 46 million 11.7 million

 

Yemen 100,800 February 24 AstraZeneca/Oxford 30 million 2.2 million

 

Zambia 907,200 January 28 N/A 18 million 4.0 million

Zimbabwe 2.6 million January 19 N/A 15 million 3.5 million

EUROPE

COUNTRY LATEST DELIVERY VACCINE TYPE POPULATION TOTAL

DELIVERY DATE DELIVERED

Albania 40,800 June 2 AstraZeneca/Oxford 2.8 million 120,000

Armenia 187,200 September 5 AstraZeneca/Oxford 3.0 million 261,200

Azerbaijan 84,000 April 4 AstraZeneca/Oxford 10 million 84,000

 

Bosnia 32,760 May 10 Pfizer/BioNTech 3.3 million 82,560

Georgia 43,200 March 13 AstraZeneca/Oxford 3.7 million 43,200

Kosovo 515,970 February 10 Pfizer/BioNTech 1.8 million 1.2 million

Moldova 100,620 January 27 Pfizer/BioNTech 2.6 million 744,620

Montenegro 24,000 March 28 AstraZeneca/Oxford 622,000 24,000

North 250,380 February 7 Pfizer/BioNTech 2.1 million 312,780

Macedonia

Serbia 115,200 August 25 AstraZeneca/Oxford 6.9 million 292,800

Ukraine 1.0 million January 19 Pfizer/BioNTech 44 million 8.8 million

ASIA & PACIFIC

COUNTRY LATEST DELIVERY DELIVERY VACCINE TYPE POPULATION TOTAL

DATE DELIVERED

Afghanistan 2.0 million February 2 J&J 39 million 9.0 million

Bangladesh 342,400 February 2 Pfizer/BioNTech 165 million 34.8 million

Brunei 24,000 April 2 AstraZeneca/Oxford 437,000 24,000

Cambodia 300,000 December 19 AstraZeneca/Oxford 17 million 2.9 million

East Timor 100,620 February 12 Pfizer/BioNTech 1.3 million 494,040

Fiji 50,400 November 18 Moderna 896,000 302,480

Indonesia 2.6 million January 28 AstraZeneca/Oxford 274 million 48.8 million

Kiribati 56,000 August 21 AstraZeneca/Oxford 119,000 104,000

Kyrgyzstan 149,760 February 1 Pfizer/BioNTech 6.6 million 800,300

Laos 1.7 million January 26 Pfizer/BioNTech 7.3 million 7.6 million

Malaysia 559,200 September AstraZeneca/Oxford 32 million 1.4 million

17

Maldives 210,600 January 28 Pfizer/BioNTech 541,000 664,540

Mongolia 899,730 October 6 Pfizer/BioNTech 3.3 million 1.3 million

Nauru 7,200 April 2 AstraZeneca/Oxford 10,830 7,200

Nepal 800,000 February 7 AstraZeneca/Oxford 29 million 14.2 million

Pakistan 1.5 million December 28 Moderna 221 million 39.1 million

Papua New 302,400 August 6 J&J 8.9 million 580,400

Guinea

Philippines 3.4 million February 15 Pfizer/BioNTech 110 million 51.8 million

Samoa 112,000 August 23 AstraZeneca/Oxford 198,410 136,000

Solomon 100,620 November 16 Pfizer/BioNTech 687,000 209,420

Islands

Sri Lanka 820,000 December 20 Pfizer/BioNTech 22 million 5.0 million

Tajikistan 501,200 February 21 AstraZeneca/Oxford 9.5 million 5.4 million

Tonga 7,000 February 15 N/A 106,000 67,800

Tuvalu 4,800 April 8 AstraZeneca/Oxford 11,800 4,800

Uzbekistan 2.8 million February 17 Moderna 34 million 12.7 million

Vanuatu 24,000 May 19 AstraZeneca/Oxford 307,000 24,000

Vietnam 6.3 million January 25 Pfizer/BioNTech 97 million 38.7 million

AMERICAS

COUNTRY LATEST DELIVERY VACCINE TYPE POPULATION TOTAL

DELIVERY DATE DELIVERED

Antigua and 19,200 November 22 N/A 98,000 60,000

Barbuda

Argentina 960,400 October 12 AstraZeneca/Oxford 45 million 3.9 million

Bahamas 57,330 October 18 Pfizer/BioNTech 393,000 124,530

Barbados 14,040 December 16 Pfizer/BioNTech 287,000 114,840

Belize 58,500 October 26 Pfizer/BioNTech 398,000 159,300

Bermuda 9,600 April 6 AstraZeneca/Oxford 64,000 9,600

Bolivia 1.3 million February 16 Pfizer/BioNTech 12 million 8.0 million

Brazil 2.0 million September 20 Sinovac 213 million 11.9 million

Chile 331,000 May 20 AstraZeneca/Oxford 19 million 489,400

Colombia 5.5 million January 3 Pfizer/BioNTech 51 million 16.5 million

Costa Rica 1.0 million February 11 Pfizer/BioNTech 5.1 million 1.4 million

Dominica 30,240 February 4 Moderna 72,000 133,920

Dominican 184,800 August 27 AstraZeneca/Oxford 11 million 463,200

Republic

Ecuador 1.5 million February 15 Pfizer/BioNTech 18 million 3.8 million

El Salvador 188,370 August 27 Pfizer/BioNTech 6.5 million 3.6 million

Grenada 69,030 December 16 Pfizer/BioNTech 113,000 114,630

Guatemala 680,940 January 27 Pfizer/BioNTech 17 million 5.0 million

Guyana 28,800 January 14 J&J 787,000 291,540

Haiti 151,200 February 14 Moderna 11 million 1.1 million

Honduras 250,040 October 28 Moderna 9.9 million 4.8 million

Jamaica 100,000 February 21 AstraZeneca/Oxford 3.0 million 1.7 million

Mexico 2.2 million May 27 AstraZeneca/Oxford 129 million 3.3 million

Nicaragua 993,600 January 24 J&J 6.6 million 4.7 million

Panama 74,400 September 15 AstraZeneca/Oxford 4.3 million 148,800

Paraguay 466,830 January 24 Pfizer/BioNTech 7.1 million 1.7 million

Peru 1.2 million November 10 Sinopharm 33 million 3.6 million

Saint Kitts and 21,600 April 7 AstraZeneca/Oxford 53,000 21,600

Nevis

Saint Lucia 7,200 December 28 J&J 184,000 197,430

Saint Vincent 70,200 December 14 Pfizer/BioNTech 111,000 115,800

and the

Grenadines

Suriname 64,800 December 14 AstraZeneca/Oxford 587,000 144,000

Trinidad and 84,000 November 27 Sinopharm 1.4 million 185,200

Tobago

Uruguay 50,400 September 1 AstraZeneca/Oxford 3.5 million 148,800

Venezuela 3.1 million January 17 Sinopharm 28 million 12.1 million

Sources: WHO, UNICEF, GAVI, releases from local authorities

 

(Compiled by Marta Frackowiak, Antonis Pothitos, Boleslaw Lasocki, Antonis Triantafyllou, Aleksandra Jasiurska and Elizaveta Gladun; Edited by David Evans and Bernadette Baum)

Health

What’s the greatest holiday gift: lips, hair, skin? Give the gift of great skin this holiday season

Published

 on

Give the gift of great skin this holiday season

Skinstitut Holiday Gift Kits take the stress out of gifting

Toronto, October 31, 2024 – Beauty gifts are at the top of holiday wish lists this year, and Laser Clinics Canada, a leader in advanced beauty treatments and skincare, is taking the pressure out of seasonal shopping. Today, Laser Clincs Canada announces the arrival of its 2024 Holiday Gift Kits, courtesy of Skinstitut, the exclusive skincare line of Laser Clinics Group.

In time for the busy shopping season, the limited-edition Holiday Gifts Kits are available in Laser Clinics locations in the GTA and Ottawa. Clinics are conveniently located in popular shopping centers, including Hillcrest Mall, Square One, CF Sherway Gardens, Scarborough Town Centre, Rideau Centre, Union Station and CF Markville. These limited-edition Kits are available on a first come, first served basis.

“These kits combine our best-selling products, bundled to address the most relevant skin concerns we’re seeing among our clients,” says Christina Ho, Senior Brand & LAM Manager at Laser Clinics Canada. “With several price points available, the kits offer excellent value and suit a variety of gift-giving needs, from those new to cosmeceuticals to those looking to level up their skincare routine. What’s more, these kits are priced with a savings of up to 33 per cent so gift givers can save during the holiday season.

There are two kits to select from, each designed to address key skin concerns and each with a unique theme — Brightening Basics and Hydration Heroes.

Brightening Basics is a mix of everyday essentials for glowing skin for all skin types. The bundle comes in a sleek pink, reusable case and includes three full-sized products: 200ml gentle cleanser, 50ml Moisture Defence (normal skin) and 30ml1% Hyaluronic Complex Serum. The Brightening Basics kit is available at $129, a saving of 33 per cent.

Hydration Heroes is a mix of hydration essentials and active heroes that cater to a wide variety of clients. A perfect stocking stuffer, this bundle includes four deluxe products: Moisture 15 15 ml Defence for normal skin, 10 ml 1% Hyaluronic Complex Serum, 10 ml Retinol Serum and 50 ml Expert Squalane Cleansing Oil. The kit retails at $59.

In addition to the 2024 Holiday Gifts Kits, gift givers can easily add a Laser Clinic Canada gift card to the mix. Offering flexibility, recipients can choose from a wide range of treatments offered by Laser Clinics Canada, or they can expand their collection of exclusive Skinstitut products.

 

Brightening Basics 2024 Holiday Gift Kit by Skinstitut, available exclusively at Laser Clincs Canada clinics and online at skinstitut.ca.

Hydration Heroes 2024 Holiday Gift Kit by Skinstitut – available exclusively at Laser Clincs Canada clinics and online at skinstitut.ca.

Continue Reading

Health

Here is how to prepare your online accounts for when you die

Published

 on

 

LONDON (AP) — Most people have accumulated a pile of data — selfies, emails, videos and more — on their social media and digital accounts over their lifetimes. What happens to it when we die?

It’s wise to draft a will spelling out who inherits your physical assets after you’re gone, but don’t forget to take care of your digital estate too. Friends and family might treasure files and posts you’ve left behind, but they could get lost in digital purgatory after you pass away unless you take some simple steps.

Here’s how you can prepare your digital life for your survivors:

Apple

The iPhone maker lets you nominate a “ legacy contact ” who can access your Apple account’s data after you die. The company says it’s a secure way to give trusted people access to photos, files and messages. To set it up you’ll need an Apple device with a fairly recent operating system — iPhones and iPads need iOS or iPadOS 15.2 and MacBooks needs macOS Monterey 12.1.

For iPhones, go to settings, tap Sign-in & Security and then Legacy Contact. You can name one or more people, and they don’t need an Apple ID or device.

You’ll have to share an access key with your contact. It can be a digital version sent electronically, or you can print a copy or save it as a screenshot or PDF.

Take note that there are some types of files you won’t be able to pass on — including digital rights-protected music, movies and passwords stored in Apple’s password manager. Legacy contacts can only access a deceased user’s account for three years before Apple deletes the account.

Google

Google takes a different approach with its Inactive Account Manager, which allows you to share your data with someone if it notices that you’ve stopped using your account.

When setting it up, you need to decide how long Google should wait — from three to 18 months — before considering your account inactive. Once that time is up, Google can notify up to 10 people.

You can write a message informing them you’ve stopped using the account, and, optionally, include a link to download your data. You can choose what types of data they can access — including emails, photos, calendar entries and YouTube videos.

There’s also an option to automatically delete your account after three months of inactivity, so your contacts will have to download any data before that deadline.

Facebook and Instagram

Some social media platforms can preserve accounts for people who have died so that friends and family can honor their memories.

When users of Facebook or Instagram die, parent company Meta says it can memorialize the account if it gets a “valid request” from a friend or family member. Requests can be submitted through an online form.

The social media company strongly recommends Facebook users add a legacy contact to look after their memorial accounts. Legacy contacts can do things like respond to new friend requests and update pinned posts, but they can’t read private messages or remove or alter previous posts. You can only choose one person, who also has to have a Facebook account.

You can also ask Facebook or Instagram to delete a deceased user’s account if you’re a close family member or an executor. You’ll need to send in documents like a death certificate.

TikTok

The video-sharing platform says that if a user has died, people can submit a request to memorialize the account through the settings menu. Go to the Report a Problem section, then Account and profile, then Manage account, where you can report a deceased user.

Once an account has been memorialized, it will be labeled “Remembering.” No one will be able to log into the account, which prevents anyone from editing the profile or using the account to post new content or send messages.

X

It’s not possible to nominate a legacy contact on Elon Musk’s social media site. But family members or an authorized person can submit a request to deactivate a deceased user’s account.

Passwords

Besides the major online services, you’ll probably have dozens if not hundreds of other digital accounts that your survivors might need to access. You could just write all your login credentials down in a notebook and put it somewhere safe. But making a physical copy presents its own vulnerabilities. What if you lose track of it? What if someone finds it?

Instead, consider a password manager that has an emergency access feature. Password managers are digital vaults that you can use to store all your credentials. Some, like Keeper,Bitwarden and NordPass, allow users to nominate one or more trusted contacts who can access their keys in case of an emergency such as a death.

But there are a few catches: Those contacts also need to use the same password manager and you might have to pay for the service.

___

Is there a tech challenge you need help figuring out? Write to us at onetechtip@ap.org with your questions.

Source link

Continue Reading

Health

Pediatric group says doctors should regularly screen kids for reading difficulties

Published

 on

 

The Canadian Paediatric Society says doctors should regularly screen children for reading difficulties and dyslexia, calling low literacy a “serious public health concern” that can increase the risk of other problems including anxiety, low self-esteem and behavioural issues, with lifelong consequences.

New guidance issued Wednesday says family doctors, nurses, pediatricians and other medical professionals who care for school-aged kids are in a unique position to help struggling readers access educational and specialty supports, noting that identifying problems early couldhelp kids sooner — when it’s more effective — as well as reveal other possible learning or developmental issues.

The 10 recommendations include regular screening for kids aged four to seven, especially if they belong to groups at higher risk of low literacy, including newcomers to Canada, racialized Canadians and Indigenous Peoples. The society says this can be done in a two-to-three-minute office-based assessment.

Other tips encourage doctors to look for conditions often seen among poor readers such as attention-deficit hyperactivity disorder; to advocate for early literacy training for pediatric and family medicine residents; to liaise with schools on behalf of families seeking help; and to push provincial and territorial education ministries to integrate evidence-based phonics instruction into curriculums, starting in kindergarten.

Dr. Scott McLeod, one of the authors and chair of the society’s mental health and developmental disabilities committee, said a key goal is to catch kids who may be falling through the cracks and to better connect families to resources, including quicker targeted help from schools.

“Collaboration in this area is so key because we need to move away from the silos of: everything educational must exist within the educational portfolio,” McLeod said in an interview from Calgary, where he is a developmental pediatrician at Alberta Children’s Hospital.

“Reading, yes, it’s education, but it’s also health because we know that literacy impacts health. So I think that a statement like this opens the window to say: Yes, parents can come to their health-care provider to get advice, get recommendations, hopefully start a collaboration with school teachers.”

McLeod noted that pediatricians already look for signs of low literacy in young children by way of a commonly used tool known as the Rourke Baby Record, which offers a checklist of key topics, such as nutrition and developmental benchmarks, to cover in a well-child appointment.

But he said questions about reading could be “a standing item” in checkups and he hoped the society’s statement to medical professionals who care for children “enhances their confidence in being a strong advocate for the child” while spurring partnerships with others involved in a child’s life such as teachers and psychologists.

The guidance said pediatricians also play a key role in detecting and monitoring conditions that often coexist with difficulty reading such as attention-deficit hyperactivity disorder, but McLeod noted that getting such specific diagnoses typically involves a referral to a specialist, during which time a child continues to struggle.

He also acknowledged that some schools can be slow to act without a specific diagnosis from a specialist, and even then a child may end up on a wait list for school interventions.

“Evidence-based reading instruction shouldn’t have to wait for some of that access to specialized assessments to occur,” he said.

“My hope is that (by) having an existing statement or document written by the Canadian Paediatric Society … we’re able to skip a few steps or have some of the early interventions present,” he said.

McLeod added that obtaining specific assessments from medical specialists is “definitely beneficial and advantageous” to know where a child is at, “but having that sort of clear, thorough assessment shouldn’t be a barrier to intervention starting.”

McLeod said the society was partly spurred to act by 2022’s “Right to Read Inquiry Report” from the Ontario Human Rights Commission, which made 157 recommendations to address inequities related to reading instruction in that province.

He called the new guidelines “a big reminder” to pediatric providers, family doctors, school teachers and psychologists of the importance of literacy.

“Early identification of reading difficulty can truly change the trajectory of a child’s life.”

This report by The Canadian Press was first published Oct. 23, 2024.

Source link

Continue Reading

Trending